Novo Nordisk Ups Rollout of Wegovy
Wall Street Journal
Novo Nordisk has started to gradually increase the supply of lower-dose strengths of its blockbuster Wegovy weight-loss drug, having limited supply in the U.S. since May to safeguard supplies.
Wall Street Journal
Novo Nordisk has started to gradually increase the supply of lower-dose strengths of its blockbuster Wegovy weight-loss drug, having limited supply in the U.S. since May to safeguard supplies.